More importantly, FABP4 has been shown to have pleiotropic effects in steatosis, NAFLD, insulin resistance and metabolic syndrome as well as in cell differentiation and chronic inflammation through macrophage activation51. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.